Top biopharmaceutical companies in cardiometabolic care worldwide 2020

Published by
Matej Mikulic,
Aug 28, 2023
In 2020, the highest total revenue made by a biopharmaceutical companies specialized in cardiometabolic care worldwide was around 28 billion U.S. dollars by Eli Lilly. This statistic illustrates the total revenue of leading biopharmaceutical companies in cardiometabolic worldwide.

Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

November 2021

Region

Worldwide

Survey time period

2020

Supplementary notes

* The table lists the most valuable branded players whose leading product(s) are in the cardiometabolic field.
Major players in diabetes care that are not listed here due to the strength of other franchise areas include Merck and Sanofi.
Beyond diabetes care, core drivers in the cardiometabolic disease area were legacy sales from statins/blood pressure medications and novel anticoagulants led by Bayer with Xarelto.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharma and biotech M&A activity "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharma and biotech M&A activity

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu